Some patients may have coverage for diabetes indications but not weight management, affecting access to higher-dose injectable semaglutide
Semaglutide, recognized as a glucagon-like peptide receptor agonist (GLP-1 RA), is the active ingredient in Wegovy, a popular injectable medication that is FDA-approved for long-term weight management
The metabolite is known to readily cross the bloodbrain barrier (BBB) 7,8 and promote analgesic and antipyretic effects through mechanisms not yet fully elucidated, but which appear to involve complex metabolic pathways (e.g., prostaglandin synthesis and nociceptive pathways) 9
What does success look like beyond weight
able to close with a tight-fitting, puncture-resistant lid, without sharps being able to come out